Topic

Articles

The addition of NEXT Oncology investigators expands Proxima CRO’s Phase I clinical trials network.

Scientists analyzing the vital substance of the blood vessels in a lab, Medical scientist for treatment concept. | Image Credit: © Puwasit Inyavileart - stock.adobe.com

NEXT Oncology Joins Proxima Clinical Research Early Phase Oncology Network 

Webcasts

Webinar Date/Time:
Wed, May 10, 2023 11:00 AM EDT 

How can Phase I data from Western medicine accelerate drug development in China and Japan?  The Science and Practice of Ethnobridging

Webinar Date/Time: Thu, Mar 2, 2023 1:00 PM EST


Accelerate Clinical Trial Success with Genomics Experts

Executive Director and Professor, Tufts University School of Medicine

The struggle to translate promising movements in R&D.

Contemplating a Pressing Drug Development Paradox 

Resource Manager, Halloran Consulting Group

Consultant, Clinical Operations, Halloran Consulting Group

Senior Manager, Consulting Operations, Halloran Consulting Group

Best practices for assessing publications.

How to Determine ‘Good Science’ for Systematic Literature Reviews in Clinical Research and Development 

Partner and Co-Chair, IP Litigation Group and Diversity, ArentFox Schiff LLP

How the digital environment can transform drug development space.

R&D Using the Metaverse and Digital Twins

SVP, Clinical Pharmacology & Translational Medicine

Oncology drug developers must start asking questions in preparation of FDA’s dose optimization initiative.

With Project Optimus, Success Favors the Prepared

Rik de Greef, senior vice president of global quantitative science services at Certara discusses the organization's training initiatives in Africa. 

Program Aims to Tap Africa's Potential in Pharmacometrics

CEO, Createrna Science and Technology, former Director of FDA’s Division of Pharmacometrics

Sirj Goswami, PhD, CEO, co-founder of InsightRX

Continued embrace of precision dosing will reduce costs and optimize clinical outcomes.

Understanding FDA’s Perspective on Precision Dosing

Gabi Hanna, MD highlights the need for an effective therapy for acute pancreatitis.

Early Phase Development